Testing effectiveness (Phase 2)Study completedNCT03132038
What this trial is testing
Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck
Who this might be right for
Salivary Gland CarcinomaMetastatic CancerRecurrent Cancer
UNICANCER 98